PlainRecalls
FDA Drug Low Class III Terminated

Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821

Reported: July 31, 2013 Initiated: May 30, 2013 #D-808-2013

Product Description

Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821

Reason for Recall

Presence of Particulate Matter; particulate found in retain samples

Details

Recalling Firm
Pharmalucence, Inc.
Units Affected
17,260 vials
Distribution
Nationwide & Bahamas, Barbados, Bermuda, Japan
Location
Billerica, MA

Frequently Asked Questions

What product was recalled?
Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821. Recalled by Pharmalucence, Inc.. Units affected: 17,260 vials.
Why was this product recalled?
Presence of Particulate Matter; particulate found in retain samples
Which agency issued this recall?
This recall was issued by the FDA Drug on July 31, 2013. Severity: Low. Recall number: D-808-2013.